[ET Net News Agency, 8 May 2024] UBS lowered the target price for Wuxi Bio (02269) to
HKD16.6 from HKD17.6 and maintained the "neutral" rating.
The research house said it fine-tuned its model and trimmed 2024/25 EPS estimates by
7.3%/6.3%. (rc)